Business Context and Reporting Period
This Form 8-K is a current report filed by Catalyst Biosciences, Inc. (not Gyre Therapeutics, Inc.) on October 25, 2017. The filing reports corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and compensation arrangements rather than financial performance.
Material Changes
- Board Expansion: The Board of Directors increased the authorized number of directors to eight members.
- Director Appointment: Andrea S. Hunt was appointed as a Class II director to fill a vacancy. Her term expires at the 2020 annual stockholders' meeting.
- Background: Ms. Hunt brings experience from Shire (Vice President of New Product Gene Therapy) and Baxter Healthcare (Vice President - Lead BAX855 and Gene Therapy).
Compensation and Outlook
As a non-employee director, Ms. Hunt received the following compensatory arrangements:
- Initial Grant: A non-qualified stock option to purchase 10,000 shares of common stock, vesting monthly over three years.
- Annual Grant: An annual non-qualified stock option to purchase 5,000 shares, vesting over one year.
- Cash Retainer: An annual cash retainer of $35,000, payable quarterly. This may be elected to be received in fully vested shares of common stock.
The filing does not contain management commentary on business outlook, risks, contingencies, or unusual items beyond the standard disclosure of the director appointment.
Investor Verification Checklist
- Verify the exact vesting schedule and exercise price of the 10,000-share initial option grant.
- Confirm whether Ms. Hunt has elected to receive her cash retainer in stock or cash for the current period.
- Review the Company's most recent 10-Q or 10-K for actual financial performance metrics, as this 8-K contains none.
- Check for any subsequent filings regarding Ms. Hunt's assignment to specific board committees.